AIMS: Diet-induced obesity is associated with increased myocardial fatty acid (FA) utilization, insulin resistance, and cardiac dysfunction. The study was designed to test the hypothesis that impaired glucose utilization accounts for initial changes in FA metabolism. METHODS AND RESULTS: Ten-week-old C57BL6J mice were fed a high-fat diet (HFD, 45% calories from fat) or normal chow (4% calories from fat). Cardiac function and substrate metabolism in isolated working hearts, glucose uptake in isolated cardiomyocytes, mitochondrial function, insulin-stimulated protein kinase B (Akt/PKB) and Akt substrate (AS-160) phosphorylation, glucose transporter 4 (GLUT4) translocation, pyruvate dehydrogenase (PDH) activity, and mRNA levels for metabolic genes were determined after 2 or 5 weeks of HFD. Two weeks of HFD reduced basal rates of glycolysis and glucose oxidation and prevented insulin stimulation of glycolysis in hearts and reduced insulin-stimulated glucose uptake in cardiomyocytes. Insulin-stimulated Akt/PKB and AS-160 phosphorylation were preserved, and PDH activity was unchanged. GLUT4 content was reduced by 55% and GLUT4 translocation was significantly attenuated. HFD increased FA oxidation rates and myocardial oxygen consumption (MVO2), which could not be accounted for by mitochondrial uncoupling or by increased expression of peroxisome proliferator activated receptor-alpha (PPAR-alpha) target genes, which increased only after 5 weeks of HFD. CONCLUSION: Rates of myocardial glucose utilization are altered early in the course of HFD because of reduced GLUT4 content and GLUT4 translocation despite normal insulin signalling to Akt/PKB and AS-160. The reciprocal increase in FA utilization is not due to PPAR-alpha-mediated signalling or mitochondrial uncoupling. Thus, the initial increase in myocardial FA utilization in response to HFD likely results from impaired glucose transport that precedes impaired insulin signalling.
AIMS: Diet-induced obesity is associated with increased myocardial fatty acid (FA) utilization, insulin resistance, and cardiac dysfunction. The study was designed to test the hypothesis that impaired glucose utilization accounts for initial changes in FA metabolism. METHODS AND RESULTS: Ten-week-old C57BL6J mice were fed a high-fat diet (HFD, 45% calories from fat) or normal chow (4% calories from fat). Cardiac function and substrate metabolism in isolated working hearts, glucose uptake in isolated cardiomyocytes, mitochondrial function, insulin-stimulated protein kinase B (Akt/PKB) and Akt substrate (AS-160) phosphorylation, glucose transporter 4 (GLUT4) translocation, pyruvate dehydrogenase (PDH) activity, and mRNA levels for metabolic genes were determined after 2 or 5 weeks of HFD. Two weeks of HFD reduced basal rates of glycolysis and glucose oxidation and prevented insulin stimulation of glycolysis in hearts and reduced insulin-stimulated glucose uptake in cardiomyocytes. Insulin-stimulated Akt/PKB and AS-160 phosphorylation were preserved, and PDH activity was unchanged. GLUT4 content was reduced by 55% and GLUT4 translocation was significantly attenuated. HFD increased FA oxidation rates and myocardial oxygen consumption (MVO2), which could not be accounted for by mitochondrial uncoupling or by increased expression of peroxisome proliferator activated receptor-alpha (PPAR-alpha) target genes, which increased only after 5 weeks of HFD. CONCLUSION: Rates of myocardial glucose utilization are altered early in the course of HFD because of reduced GLUT4 content and GLUT4 translocation despite normal insulin signalling to Akt/PKB and AS-160. The reciprocal increase in FA utilization is not due to PPAR-alpha-mediated signalling or mitochondrial uncoupling. Thus, the initial increase in myocardial FA utilization in response to HFD likely results from impaired glucose transport that precedes impaired insulin signalling.
Authors: Isabel R Schlaepfer; Leslie K Pulawa; Luis D M C-B Ferreira; David E James; Warren H Capell; Robert H Eckel Journal: J Lipid Res Date: 2003-04-16 Impact factor: 5.922
Authors: Sabine Fredersdorf; Christian Thumann; Coskun Ulucan; Daniel P Griese; Andreas Luchner; Günter A J Riegger; Eckhard P Kromer; Joachim Weil Journal: Cardiovasc Pathol Date: 2004 Jan-Feb Impact factor: 2.185
Authors: Susan L M Coort; Danny M Hasselbaink; Debby P Y Koonen; Jodil Willems; Will A Coumans; Adrian Chabowski; Ger J van der Vusse; Arend Bonen; Jan F C Glatz; Joost J F P Luiken Journal: Diabetes Date: 2004-07 Impact factor: 9.461
Authors: Linda R Peterson; Pilar Herrero; Kenneth B Schechtman; Susan B Racette; Alan D Waggoner; Zulia Kisrieva-Ware; Carmen Dence; Samuel Klein; JoAnn Marsala; Timothy Meyer; Robert J Gropler Journal: Circulation Date: 2004-05-03 Impact factor: 29.690
Authors: L Bergandi; F Silvagno; I Russo; C Riganti; G Anfossi; E Aldieri; D Ghigo; M Trovati; A Bosia Journal: Arterioscler Thromb Vasc Biol Date: 2003-11-13 Impact factor: 8.311
Authors: Xiangping Fang; Rengasamy Palanivel; Justin Cresser; Kristin Schram; Riya Ganguly; Farah S L Thong; Joseph Tuinei; Aimin Xu; E Dale Abel; Gary Sweeney Journal: Am J Physiol Endocrinol Metab Date: 2010-08-24 Impact factor: 4.310
Authors: Olesya Ilkun; Nicole Wilde; Joseph Tuinei; Karla M P Pires; Yi Zhu; Heiko Bugger; Jamie Soto; Benjamin Wayment; Curtis Olsen; Sheldon E Litwin; E Dale Abel Journal: J Mol Cell Cardiol Date: 2015-05-22 Impact factor: 5.000
Authors: Christopher Schafer; Zachary T Young; Catherine A Makarewich; Abdallah Elnwasany; Caroline Kinter; Michael Kinter; Luke I Szweda Journal: J Biol Chem Date: 2018-03-14 Impact factor: 5.157